title: The use of the GnRH analogue buserelin for IVF--does it improve fertility?
abstract: OBJECTIVE
  To determine the effect of a short course of the GnRH analogue buserelin and human menopausal gonadotrophin (hMG), for ovarian stimulation in our IVF programme, on reproductive endocrinology and pregnancy rates compared with conventional clomiphene citrate and hMG treatment.
  
  
  METHODS
  Prospective randomized allocation to one of two ovulation stimulation regimens.
  
  
  METHODS
  Fertility clinic.
  
  
  METHODS
  373 infertile couples with various factors associated with their subfertility. All the women were less than 46 years of age and had normal menstrual cycles.
  
  
  METHODS
  The first group (n = 151) was given clomiphene citrate (CC) from days 2-6 of the menstrual cycle and hMG from day 5 onwards (CC/hMG). The second group (n = 222) was given buserelin from days 1-3 and hMG from day 2 (buserelin/hMG).
  
  
  METHODS
  Concentration of plasma luteinizing hormone (LH), oestradiol (E2) and progesterone, number of ovulatory follicles induced and the occurrence of pregnancy.
  
  
  RESULTS
  Plasma LH, E2 and progesterone concentrations were reduced in the late follicular phase after buserelin/hMG compared with CC/hMG. Buserelin/hMG promoted the development of more follicles than CC/hMG. The overall pregnancy rate after buserelin/hMG was not significantly different from that following CC/hMG treatment.
  
  
  CONCLUSIONS
  The chance of pregnancy is not improved by the short-term use of buserelin with hMG, provided adequate follicular phase management is maintained.
authors.affiliation: AMI Park Hospital, Fertility Services Unit, Arnold, Nottingham.
authors.forename: K
authors.initials: K
authors.lastname: Shelton
authors.forename: S
authors.initials: S
authors.lastname: Fishel
authors.forename: P
authors.initials: P
authors.lastname: Jackson
authors.forename: J
authors.initials: J
authors.lastname: Webster
authors.forename: B
authors.initials: B
authors.lastname: Faratian
authors.forename: J
authors.initials: J
authors.lastname: Johnson
mesh_terms: D000328:Adult; D002064:Buserelin / Q000008:administration & dosage*; D002996:Clomiphene / Q000008:administration & dosage; D004958:Estradiol / Q000097:blood; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008596:Menotropins / Q000008:administration & dosage; D008875:Middle Aged; D006080:Ovarian Follicle / Q000187:drug effects; D011374:Progesterone / Q000097:blood
chemical_list: D002996:Clomiphene; D011374:Progesterone; D004958:Estradiol; D008596:Menotropins; D007986:Luteinizing Hormone; D002064:Buserelin